Results 251 to 260 of about 158,043 (302)

Control, Fludrocortisone or Midodrine for the treatment of Orthostatic Hypotension (CONFORM-OH): Results from an internal pilot randomised controlled trial

Mossop H, Al-Ashmori S, Sotire T, Clark E, Watson G, Witham MD, Vale L, McGregor N, Phillipson J, Wason JMS, Yarnall AJ, Parry S, Hancock H, Kenny RA, Frith J.   +14 more
europepmc   +1 more source

Atomoxetine on neurogenic orthostatic hypotension: a randomized, double-blind, placebo-controlled crossover trial. [PDF]

Clin Auton Res
Mwesigwa N, Millar Vernetti P, Kirabo A, Black B, Ding T, Martinez J, Palma JA, Biaggioni I, Kaufmann H, Shibao CA.   +9 more
europepmc   +1 more source

Orthostatic hypotension is associated with higher levels of circulating endostatin. [PDF]

Eur Heart J Open
Ricci F, Larsson A, Ruge T, Galanti K, Hamrefors V, Sutton R, Olshansky B, Fedorowski A, Johansson M.   +8 more
europepmc   +1 more source

Advice to People with Parkinson's in My Clinic: Orthostatic Hypotension. [PDF]

J Parkinsons Dis
Lamotte G, McKee KE, Luthra NS, Corcos DM.   +3 more
europepmc   +1 more source

Norepinephrine Reuptake Inhibition, an Emergent Treatment for Neurogenic Orthostatic Hypotension. [PDF]

Hypertension
Mwesigwa N, Shibao CA.
europepmc   +1 more source

Cardiac autonomic neuropathy: impact on severe hypoglycemic unawareness and orthostatic hypotension in diabetic dysautonomia, a case series and review. [PDF]

Cardiovasc Endocrinol Metab
Wu C, Devireddy R, Zazaian A, Kambhatla S, Alzohaili O, Saad C.   +5 more
europepmc   +1 more source

Case report: orthostatic hypotension as the first presentation of progressive encephalomyelitis with rigidity and myoclonus (PERM) with multiple autoimmune antibodies. [PDF]

BMC Neurol
Song J, Hu S, Chen L, Lan C, Lu P.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Orthostatic Hypotension in Hypertensive Adults: Harry Goldblatt Award for Early Career Investigators 2021

HYPERTENSION, 2022
Orthostatic hypotension affects roughly 10% of individuals with hypertension and is associated with several adverse health outcomes, including dementia, cardiovascular disease, stroke, and death.
Inbar Raber, Matthew J. Belanger, Rosemary B. Farahmand, Rahul Aggarwal, Nicholas Chiu, Mahmoud Al Rifai, A. Jacobsen, L. Lipsitz, S. Juraschek   +8 more
semanticscholar   +1 more source

Orthostatic hypotension

Clinics in Geriatric Medicine, 2002
A common problem among elderly people, orthostatic hypotension is associated with significant morbidity and mortality, which may be caused by medications, the cumulative effects of age- and hypertension-related alterations in blood pressure regulation, or age-associated diseases that impair autonomic function.
Seiji, Mukai, Lewis A, Lipsitz
openaire   +2 more sources

Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension

Annals of Neurology, 2020
The purpose of this study was to evaluate if the cognitive benefit of rivastigmine is affected by the presence of orthostatic hypotension (OH) in patients with Parkinson's disease dementia (PDD).
A. Espay, L. Marsili, A. Mahajan, Andrea Sturchio, R. Pathan, A. Pilotto, Damodaran Solai Elango, N. Pezous, M. Masellis, B. Gomez-Mancilla   +9 more
semanticscholar   +1 more source